Compound 854
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(N)c1)c1c2[nH]n(-c2ccc(F)cc2)c1=O
- InChi:
InChI=1S/C20H15FN6O/c1-26-19-15(10-23-26)18-16(17(24-19)11-3-2-4-13(22)9-11)20(28)27(25-18)14-7-5-12(21)6-8-14/h2-10,25H,22H2,1H3
- InChiKey:
YZRQBRVRVKEHSG-UHFFFAOYSA-N
External links
168318049 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.40 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 374.13 g/mol | |||
HBA | 7 | |||
HBD | 3 | |||
HBA + HBD | 10 | |||
AlogP | 3.43 | |||
TPSA | 89.07 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4921 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4829 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4826 | Riociguat | DB08931 | |
0.4815 | ATX-914 | DB12673 | |
0.4664 | Vericiguat | DB15456 | |
0.4635 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4619 | Dilmapimod | DB12140 | |
0.4570 | Neflamapimod | DB07138 | |
0.4570 | Ravoxertinib | DB15281 | |
0.4546 | 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | DB08054 | |
0.4533 | Tepotinib | DB15133 | |
0.4455 | 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB07210 | |
0.4449 | Merestinib | DB12381 | |
0.4440 | Risdiplam | DB15305 | |
0.4427 | ABT-288 | DB15192 |